Fractalkine (CX3CL1): a biomarker reflecting symptomatic severity in patients with knee osteoarthritis.
Huo, Li Wei
Fractalkine (CX3CL1): a biomarker reflecting symptomatic severity in patients with knee osteoarthritis. [electronic resource] - Journal of investigative medicine : the official publication of the American Federation for Clinical Research Apr 2015 - 626-31 p. digital
Publication Type: Journal Article
1708-8267
10.1097/JIM.0000000000000158 doi
Aged
Biomarkers--blood
Case-Control Studies
Chemokine CX3CL1--blood
Female
Humans
Male
Middle Aged
Osteoarthritis, Knee--blood
Severity of Illness Index
Synovial Fluid--metabolism
Fractalkine (CX3CL1): a biomarker reflecting symptomatic severity in patients with knee osteoarthritis. [electronic resource] - Journal of investigative medicine : the official publication of the American Federation for Clinical Research Apr 2015 - 626-31 p. digital
Publication Type: Journal Article
1708-8267
10.1097/JIM.0000000000000158 doi
Aged
Biomarkers--blood
Case-Control Studies
Chemokine CX3CL1--blood
Female
Humans
Male
Middle Aged
Osteoarthritis, Knee--blood
Severity of Illness Index
Synovial Fluid--metabolism